These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results Terminated 2004-001590-26 NATIONAL, MULTICENTER, RANDOMIZED,OPEN STUDY TO EVALUATE EFFICACY AND SAFETY OF LAMIVUDINE (300 MG QD) MONOTHERAPY AS AN ALTERNATIVE TO THERAPEUTIC INTERRUPTION IN PAZIENTS AFFECTED BY HIV-1, IN VIRAL... 2006-02-24 due-trials
Ongoing 2004-001601-10 Evaluation d’une nouvelle stratégie thérapeutique chez des patients à fort risque évolutif, à la phase initiale de la sclérose en plaques : traitement séquentiel par mitoxantrone (Elsep 10mg/m² par mo... not-yet-due
Reported results 2004-001673-25 EFFECTS OF ANGIOTENSIN RECEPTOR ANTAGONIST ON CHRONIC NEPHROPATY IN KIDNEY TRANSPLANTED PATIENTS. A PILOT STUDY. 2011-12-16 due-trials
Reported results Terminated 2004-001827-39 NATIONAL, MULTICENTER, RANDOMISED, OPEN STUDY TO VALUATE THE EFFICACY OF DIFFERENT THERAPEUTIC STRATEGIES TO AVOID THE IMMUNOLOGIC FAILURE IN MULTIRESISTENT HIV-1 INFECTED PATIENTS. 2006-04-10 due-trials
Reported results 2004-004287-71 THE EFFECT OF REMIFENTANIL ON DESFLURANE REQUIREMENTS FOR SYMPATHETIC RESPONSES TO SURGICAL INCISION. 2005-09-01 due-trials
Reported results Terminated 2004-004316-23 Randomised, controlled , double blind trial on emodinamic, analgesic, pharmacoeconomic effects of clonidine and magnesium in premedication of laparoscopic surgery for colecitis ablation. 2005-05-10 due-trials
Reported results 2004-004337-33 RANDOMIZED COMPARISON OF CIRCUMFERENTIAL PULMONARY VEIN ABLATION VERSUS ANTIARRHYTHMIC THERAPY FOR CURING PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION. (APAF STUDY) 2006-11-26 due-trials
Reported results 2004-004481-33 Vorionazole for IFI prophilaxis in oncoematologic patients. 2007-03-29 due-trials
Ongoing 2004-004723-35 PRECONDITIONING EFFECT OF INALATORY ANESTHETICS EFFETTO DI PRECONDIZIONAMENTO DEGLI ANESTETICI INALATORI not-yet-due
Reported results 2005-000170-40 EFFECT OF AN ORAL DOSE OF FERROUS SULFATE ON URINARY ESCRETION OF EPCIDINA IN PATIENTS AFFECTED BY EMOCROMATOSI. 2007-01-31 due-trials
Reported results 2005-001398-86 POSTOPERATIVE RADIOCHEMIOTHERAPY WITH SIB IN NEOPLASTIC DISEASE OF CERVICO-FACIAL DISTRICT IN LOCALLY ADVANCED STATUS : PHASE I-II STUDY 2008-09-17 due-trials
Reported results 2005-001971-36 PILOT, OPEN NON COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICAY AND SAFETY OF RETAANE (ANECORTAVE ACETATO 15 MG, 0.5 ML DI 30 MG/ML ANECORTAVE ACETATO STERILE SUSPENSION) IN PATIENTS WITH COROIDEAL... 2007-07-31 due-trials
Reported results Terminated 2005-002527-14 PREDICTIVE PERFORMANCE OF ''TARGET CONTROLLED INFUSION'' OF PROPOFOL ASSOCIATED WITH NEUROPHISIOLOGIC MONITORING WITH BISPECTRAL INDEX AND CEREBRAL STATE INDEX IN PATIENT WITH ELEVATED ANESTESIOLOGIC ... 2009-10-06 due-trials
Completed, but no date, and reported results 2005-002586-36 PEXG VERSUS PDXG IN LOCALLY ADVANCED OR METASTATIC PANCREATIC ADENOCARCINOMA : RANDOMIZED, PHASE II STUDY. bad-data
Reported results 2005-004639-24 Pharmacological intervention study with L-arginin in prevention of diabete type II in patients affected by metabolic syndrome. 2009-09-05 due-trials
Reported results 2005-005182-11 Clinical phase II trial to evaluate the safety and efficacy of treosulfan based conditioning prior to allogenic haematopoietic stem cell transplantation in patients with haematological malignancies. 2012-01-11 due-trials
Ongoing 2005-005199-33 EFFICACY OF DESMOPRESSINA IN PATIENT WITH ACTIVE BLEEDING AFTER HEART SURGERY. not-yet-due
Ongoing 2005-005679-13 An open-label, prospective, multicentric pilot study evaluating safety and symptomatics effects of low dose Naltrexone in patients with primary progressive multiple sclerosis. not-yet-due
Reported results 2005-005692-15 Evaluation of bio-clinician plus of perisurgery administration of Metilprednisolone MP in high doses in short term in laparotomy and laparoscopic colic surgeryfor neoplastic patology. Prospective, c... 2018-02-15 due-trials
Reported results Terminated 2006-001163-29 RESCUE CHEMIOTERAPY WITH MI Mitomicina e Isofosfamide in pancreatic adenocarcinoma with metastasis a phase II study. 2008-12-15 due-trials
Reported results Terminated 2006-001174-25 EFFECT OF REMIFENTANIL AND PRPOPOFOL TIMING ADMINISTRATION ON THE DEEPNESS OF HYPNOSIS. 2007-10-30 due-trials
Reported results Terminated 2006-001923-20 Palifermin use in patients , out of clinical investigation, which are receiving chemioterapic therapy with staminal cells to reduce severuty and incidence of mucositis. 2006-07-20 due-trials
Ongoing 2006-002971-42 Outpatients high-dose chemotherapy supported by autologus peripheral blood stem and single-dose pegfilgrastim in patients with lymphoproliferative malignances. not-yet-due
Ongoing 2006-003581-34 DASATINIB compassionate use not-yet-due
Ongoing 2006-003684-32 Integrilin plus stenting to avoid myocardial necrosis trial. Pilot Study not-yet-due
Reported results Terminated 2006-004968-32 Protocol for therapeutic use of Posaconazolo out of clinical trials in patients with invasive resistant micosis and/or in tolerant patients. 2006-12-11 due-trials
Ongoing 2006-005996-17 A pilot, open label, multicenter, randomized clinical trial on Lopinavir/ritonavir-monotherapy vs Lopinavir/ritonavir plus selected Nucs, in HIV/HCV ARV-naive coinfected patients with chronic hepatiti... not-yet-due
Ongoing 2006-006042-33 A pilot, open label, multicenter, randomized clinical trial on Lopinavir/Ritonavir-monotherapy vs Lopinavir/Ritonavir plus selected Nucs, in HIV/HCV coinfected patients with chronic hepatitis C or co... not-yet-due
Reported results Terminated 2006-006117-32 Tipranavir/ritonavir 500/100 mg bid as a simplification strategy in HIV-1 infected subjects with an ongoing Tipranavir 500mg/Ritonavir 200mg bid regimen and undetectable viral load. 2009-12-21 due-trials
Reported results 2006-006851-11 UTILITY IN RM OF GD-BOBPTA VERSUS GD-DTPA IN THE DEFINITION OF THE RESIDUAL OF THE ADENOMA OF THE HYPOPHYSIS. 2008-01-22 due-trials
Not reported 2006-006999-38 HIGH-DOSE SEQUENTIAL CHEMOTHERAPY AND RITUXIMAB (R-HDS) SUPPORTED BY AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH SYSTEMIC B-CELL LYMPHOMA WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT AT DIAGNOSIS... 2013-03-26 due-trials
Completed, but no date, and reported results Terminated 2007-000421-21 PROSPECTIVE, RANDOMIZED, DUOBLE BLIND COMPARISON BETWEEN SUBARACNOID ANAESTHESIA AND SUBARACNOID ANAESTHESIA WITH BLOCK OF FEMORAL NERVE IN PATIENTS UNDERGOING SURGERY FOR ANTERIOR LIGAMENT REPAIR. bad-data
Ongoing 2007-000439-24 NORA TRIAL (oral Navelbine in adjuvabt):multicenter,prospective,phase II, randomized clinical trial concerning about adjuvant chemioterapy with cisplatino and vinorelbine according to an advanced sche... not-yet-due
Reported results Terminated 2007-000586-38 HIGH-DOSE IMMUNOSUPPRESSION WITH THIOTEPA AND CYCLOPHOSPHAMIDE FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE SCLEROSIS 2013-07-08 due-trials
Reported results 2007-000763-18 ACUTE CHANGES OF ENERGETIC SUBSTRATES ON MIOCARDIAL FUNCTION AND METABOLISM, IN PATIENTS WITH CRONIC HEART FAILURE ACITRIM 2009-05-14 due-trials
Reported results Terminated 2007-003045-33 Fenoldopam and renal insufficiency 2013-06-28 due-trials
Reported results 2007-003072-19 Remifentanil administered by controlled tecnique PCSA by patients versus Meperidina administered by physician for diagnostic and operative endoscopic procedures. 2008-04-30 due-trials
Ongoing 2007-003074-26 Oral iron challange on urinary excretion of hepcidin, the key iron regulatory hormone in hemochromatosis. not-yet-due
Reported results 2007-005056-16 Atorvastatin at high dosage before coronary stent surgery: effect on peri-procedure miocardic stroke . 2009-02-13 due-trials
Ongoing 2007-005477-54 Treosulfan-based conditioning and Rapamycin-base GvHD prophylaxis prior to un-manipulated allogeneic haematopoietic stem cell transplantation from a mismatched donor in patients with high risk haemato... not-yet-due
Reported results Terminated 2007-005506-42 HIGH-DOSE SEQUENTIAL CHEMOTHERAPY AND RITUXIMAB (R-HDS) IN HIV+ PATIENTS WITH NON-HODGKIN LYMPHOMA (NHL) REFRACTORY OR RELAPSED AFTER 1st LINE TREATMENT 2013-11-07 due-trials
Ongoing 2007-006268-32 EFFICACY AND SAFETYOF BOTULINUM TOXIN THERAPY ON UPPER LIMB SPASTICITY IN INFLAMMATORY AND DEMIELINIZZATING DISEASE OF CENTRAL NERVOUS SYSTEM. not-yet-due
Ongoing 2007-006299-13 Randomised proteomic based phase II study of second-line erlotinib versus chemotherapy in patients with inoperable non-small cell lung cancer not-yet-due
Reported results Terminated 2007-007479-18 Postoperative analgesia in major ortopedic surgery: continuos epidural perfusion with laevobupivacaine 0.125% vs continuos epidural perfusion with laevobupivacaine 0.125% + sufentanil 0.5 gamma/ml. 2009-04-30 due-trials
Reported results Terminated 2008-000490-37 Pharmacological treatment with memantine of oscilloscopy in patients suffering from multiple sclerosis: randomized,double blind placebo controlled study. 2011-03-21 due-trials
Reported results 2008-000588-41 Tranexamic acid efficacy reducing surgery bleding in patients undergoing surgery for complete prostatectomy. 2010-11-30 due-trials
Completed, but no date 2008-000664-16 Clinical phase II trial to evaluate the safety and efficacy of treosulfan combined with cytarabine and fludarabine prior to autologous haematopoietic stem cell transplantation in elderly patients with... bad-data
Reported results Terminated 2008-000686-30 Effect of glicemia normalization in fasting conditions by insulinic intensive treatment on frequency of restenosis after periferic angioplastic in patients affected by diabetes mellitus type II. 2011-11-11 due-trials
Reported results 2008-000741-55 Vasovist and Gadovist in comparison to Magnevist for detection of myocardial late enhancement in MR in different cardiac diseases using the technique of delayed enhancement 2010-03-02 due-trials
Completed, but no date, and reported results 2008-000814-65 Maintenance therapy with Sunitinib in pancreatic adenocarcinoma metastatic: Phase II randomized trial. Terapia di mantenimento con Sunitinib nell'adenocarcinoma pancreatico metastatico: studio ran... bad-data
Reported results 2008-001454-40 A multi-step trial towards single donor islet transplantation in type I diabetic patients,using calcineurin inhibotor-free immunosuppression. 2009-11-16 due-trials
Reported results 2008-001752-43 CARDIAC PROTECTION WITH SEVOFLURANE IN PATIENTS WITH HIGH RISK UNDERGOING HEART SURGERY. RANDOMIZED, CONTROLLED STUDY. 2011-11-23 due-trials
Ongoing 2008-001940-38 Functional RMN study to evaluate the prompt and middle term effect of the treatment with Donepezil in patients affected by multiple sclerosis and mild impairment of cognitive function. not-yet-due
Completed, but no date 2008-003729-18 A phase II trial to evaluate the safety and activity of single-agent lenalidomide given as maintenance therapy after response to second-line therapy in patients with relapsed diffuse large B cell lymp... bad-data
Reported results Terminated 2008-003870-16 A PILOT STUDY OF SEQUENTIAL, NON-MYELOABLATIVE HLA-IDENTICAL SIBLING DONOR ALLOGENEIC STEM CELL TRANSPLANTATION FOLLOWED BY IV TEMSIROLIMUS IN PATIENTS WITH ADVANCED, TKI-REFRACTORY CLEAR-CELL RENAL C... 2011-10-19 due-trials
Ongoing 2008-006287-11 Virologic efficacy of Maraviroc in adult naive HIV patients with HIV-RNA>= 1000 copies/ml not-yet-due
Reported results 2008-006972-31 Clinical phase II trial to evaluate the safety and efficacy of clofarabine and treosulfan conditioning prior to peripheral blood stem cells transplantation in paediatric and adult patients with advanc... 2015-02-19 due-trials
Ongoing 2008-007004-29 Maraviroc in HIV Acute INfection not-yet-due
Reported results Terminated 2008-007988-16 Imatinib piu` idrossiurea nel trattamento dei meningiomi recidivati o in progressione: studio randomizzato di fase II. 2013-03-12 due-trials
Reported results 2009-010189-48 Randomised trial comparing the introduction of an immediate or deferred new HAART regimen in failing HIV infected patients: the role of lamivudine monotherapy 2012-05-28 due-trials
Ongoing 2009-010292-24 Evaluation of Metformin effect on left ventricular function and on energetic metabolism, in patients affected by heart failure and glucidic intolerance. not-yet-due
Ongoing 2009-010383-42 Comparison between two different dosages of remifentanil administered by a patient controlled tecnique (PCSA) for diagnostic and andoscopich procedures. not-yet-due
Ongoing 2009-012624-93 “Esmolol in cardiac surgery. A randomized controlled trial with clinical relevant endpoints.” not-yet-due
Ongoing 2009-013029-41 Proteomic profile analysis to classify advanced pancreatic adenocarcinoma patients for clinical outcome after treatment with PDXG (cisplatin, docetaxel, capecitabine, gemcitabine) or PEXG (cisplatin, ... not-yet-due
Ongoing 2009-013066-31 “Levosimendan to reduce mortality in high risk cardiac surgery patients. A multicentre randomized controlled trial.” not-yet-due
Ongoing 2009-013201-33 Propofol and Tiopentone in paediatric sedation for fRMI study. not-yet-due
Reported results Terminated 2009-013480-18 Evaluation of tissue with low level of oxygene in patients affected by neck and brain cancer by PET/TC with Cu-ATSM (PET-ATSM-1). 2011-12-21 due-trials
Ongoing 2009-013662-33 PROSPECTIVE EVALUATION OF SERUM MALDI TOF MS PROTEOMIC PROFILE PREDICTIVE OF OUTCOME IN PATIENTS WITH GLIOBLASTOMA MULTIFORME TREATED WITH STANDARD TREATMENT STRATIFIED ACCORDING TO MGMT not-yet-due
Reported results Terminated 2009-015958-38 Effect of xantina oxidasi inhibition on left ventricular function and on energetic stores of the haert in patients affected by chronic cardiac insufficiency. 2013-03-28 due-trials
Exempt 2009-017349-77 A Phase I/II clinical trial of hematopoietic stem cell gene therapy for the treatment of Metachromatic Leukodystrophy not-yet-due
Ongoing 2010-018709-12 Optimizing Susceptibility to CCR5 Antagonist Response not-yet-due
Ongoing 2010-018767-42 The use of Contrast Enhanced Transesophageal Echocardiography in thoracic endovascular aortic repair (TEVAR). Feasibility and safety of a new tool for intraoperative monitoring and follow up. not-yet-due
Ongoing 2010-019359-23 Randomized,controlled,open study to evaluate the response to r-TPA therapy vs clinical standard therapy in patients affected by ictus at awakening coming in ER within 3 hours from symptoms compare. not-yet-due
Ongoing 2010-019379-31 Evaluation of epatic rigeneration after G-CSF administartion in patients undergoing embolization procedure or portal vein tying forecasting resective surgery for neoplasia. not-yet-due
Ongoing 2010-019938-27 Input of tact and kinestesia in strength perception. not-yet-due
Ongoing 2010-019942-23 Randomized, fase II-III study of peri and post surgery chemiotherapy in removable pancreas carcinoma not-yet-due
Reported results 2010-020442-10 Efficacy of atazanavir/ritonavir monotherapy as maintenance in patients with viral suppression. Randomized, open label non inferiority trial. (MODAt STUDY) 2015-06-24 due-trials
Ongoing 2010-020979-23 Randomized fase II study using chemiotherapy with metformine in patients affected by pancreas metastatic cancer. not-yet-due
Reported results Terminated 2010-021651-79 Studio degli effetti immuno-virologici dell’interruzione di Maraviroc nei pazienti che stanno fallendo un regime contenente Maraviroc Viro-Immunologic Effects of Interrupting Maraviroc in Patients ... 2012-01-06 due-trials
Ongoing 2010-022808-40 A fase II, randomized, Double-Blind, Placebo-Controlled, Multicentre Study for the Safety and Efficacy on Spasticity Symptoms of a Cannabis Sativa Extract in Motor Neuron Disease Patients not-yet-due
Reported results Terminated 2010-022996-79 On demand versus daily sildenafil for patients undergoing bilateral nerve sparing radical prostatectomy: a randomized, open label, parallel group trial. 2013-10-14 due-trials
Completed, but no date, and reported results 2010-023678-38 High-field structural and functional MRI to investigate the substrates of fatigue in multiple sclerosis and to monitor the effect of tailored treatments.Pharmacological substudy. bad-data
Reported results 2010-023749-30 Studio PKCT - Pharmacokinetics of chemotherapy when given concurrently with antiretroviral (Protocol no. CSL01). Studio PKCT – Farmacocinetica dei chemioterapici antitumorali quando somministrati i... 2012-12-31 due-trials
Ongoing 2010-024210-65 Evaluation of antiplatelet drug response after load of statins in patients undergoing coronary angioplasty with stenting. Valutazione della risposta farmacologica antipiastrinica dopo carico di sta... not-yet-due
Ongoing 2010-024287-17 Salvage therapy with trabectidin in metastatic pancreatic adenocarcinoma: a single-arm phase II trial. not-yet-due
Exempt 2011-000176-33 Cell Therapy Of Duchenne Muscular Dystrophy by intra-arterial delivery of HLA-identical allogeneic mesoangioblasts not-yet-due
Ongoing 2011-000890-29 Instrumental and clinical effects of withdrawal of beta blockers therapy in patients with heart failure and right ventricular dysfunction'' Effetti clinici e strumentali della sospensione della ter... not-yet-due
Reported results Terminated 2011-000973-30 PLERIXAFOR MOBILIZED STEM CELLS AS SOURCE FOR GENE THERAPY OF BETA-THALASSEMIA AMD-THAL . Cellule staminali mobilizzate mediante Plerixafor come fonte per la terapia genica della beta-talassemia. 2012-09-30 due-trials
Ongoing 2011-001408-37 Effects of Liraglutide on left ventricular (LV) morphology, function and energy metabolism in patients with type 2 diabetes and heart failure : an in vivo cardiac Magnetic Resonance Imaging and 31P Sp... not-yet-due
Reported results 2011-001534-42 Treosulfan and 4 Gy TBI based conditioning with Rapamycin-based GvHD prophylaxis for allogeneic stem cell transplantation in patients with haematological malignancies Condizionamento a base di Tr... 2016-06-16 due-trials
Reported results Terminated 2011-002002-70 A RANDOMISED PHASE II TRIAL OF SECOND LINE THERAPY IN ADVANCED BILIARY TRACT CANCER: CAPECITABINE OR CAPECITABINE PLUS MITOMYCIN C (BIT-2) STUDIO RANDOMIZZATO DI FASE II DI CHEMIOTERAPIA DI SECONDA... 2015-05-06 due-trials
Ongoing 2011-002587-24 Effects of Aliskiren on microcirculation dysfunction in patients affected by hypertension Effetti del farmaco Aliskiren sulla disfunzione del microcircolo nei pazienti con ipertensione arteriosa not-yet-due
Completed, but no date, and reported results Terminated 2011-003487-75 Phase II trial on safety and activity of intensive short-term chemoimmunotherapy in HIV-positive patients with Burkitt's lymphoma. Studio di fase II sulla sicurezza ed attivita' di una combinazione... bad-data
Ongoing 2011-003824-12 Pilot phase II trial on safety and activity of secondary prophylaxis with Romiplostim in patients with non-Hodgkin lymphoma and chemotherapy-induced throm-bocytopenia Studio pilota di fase II sulla... not-yet-due
Ongoing 2011-004808-37 Phase II clinical study on the activity of salvage therapy with high doses of oral clarithromycin in patients with extranodal marginal zone relapsed or refractory lymphoma Studio clinico di fase II... not-yet-due
Ongoing 2011-004834-32 Administration of concentrated Protein C in patients with severe sepsis and contraindications to activated protein C. A monocentric, randomised placebo-controlled study. Somministrazione di concent... not-yet-due
Not reported 2011-004908-37 Phase II study on activity and tolerability of intralesional rituximab in relapsed or refractory patients affected by indolentCD-20 positive lymphoma of conjuntiva; evaluation of activity of adding au... 2020-03-19 due-trials
Ongoing 2012-000324-17 Administration of low doses of iodate MdC with fast speed injection in coronaric TCangiography . Somministrazione di basse dosi di MdC iodato a elevata velocita' d'iniezione in angioTC coronarica. not-yet-due
Ongoing 2012-000648-83 POSITRON EMISSION TOMOGRAPHY/COMPUTERIZED TOMOGRAPHY/ECOCONTRAT OF THE PLAQUE ASSOCIATED WITH CEREBRAL MAGNETIC RESONANCE FOR THE CHARACTERISATION OF THE LESION IN VIVO INTIMA-MEDIA THICKENING ATHEROS... not-yet-due
Reported results 2012-001755-40 Propofol TCI (Target Controlled Infusion) vs. Fentanyl plus Midazolam for moderate sedation during endoscopy diagnostic procedures: a prospective, double-blind randomized trial. Sedazione moderata ... 2014-03-04 due-trials
Ongoing 2012-003151-11 An open-label, single-arm, phase II, prospective, pilot study of tocilizumab in patients with Erdheim-Chester disease. Trial clinico pilota di fase II, in aperto, prospettico, a braccio singolo con... not-yet-due
Ongoing 2012-003164-50 CONTRAST ENHANCED ULTRASOUND (CEUS) IN UVEAL MELANOMA: QUANTITATIVE ASSESSMENT OF TUMOR RESPONSE TO GAMMA KNIFE RADIOSURGERY (GKR) ECOGRAFIA CON MEZZO DI CONTRASTO (CEUS) NEL MELANOMA UVEALE: VALU... not-yet-due
Ongoing 2012-004328-40 IMAGING OF NEUROINFLAMMATION IN NEURODEGENERATIVE DISEASES INMIND STUDIO DELLA NEUROINFIAMMAZIONE NELLE PATOLOGIE NEURODEGENERATIVE not-yet-due
Reported results 2012-004556-11 Randomized,multicenter,open-label, study of monoterapy with darunavir/ritonavir or lopinavir/ritonavir vs standard of care in virologically suppressed HIV-infected patients. Studio randomizzato, in... 2015-08-03 due-trials
Reported results 2013-003898-98 COMPARISON OF WHITE LIGHT TUR VS PHOTODYNAMIC DIAGNOSIS (PDD)- GUIDED TUR AS ASSESSED BY SECOND LOOK TUR FOR THE TREATMENT OF HIGH RISK NON MUSCLE INVASIVE BLADDER CANCER (NMIBC) IMPATTO DELLA RESE... 2016-12-15 due-trials
Ongoing 2013-004916-23 Monotherapy with Ofatumumab for RElapsed/refractory Splenic B-cell marginal zone lymphoma (MORE) Monoterapia con Ofatumumab per pazienti affetti da linfoma marginale splenico in ricaduta/REfrattari... not-yet-due
Ongoing 2013-005054-30 A mechanistic study to evaluate the effect of Serelaxin on left ventricular function and its correlation with outcome in acute heart failure not-yet-due
Not reported 2013-005533-20 VOLATILE ANESTHETICS TO REDUCE MORTALITY IN CARDIAC SURGERY. A MULTICENTRE RANDOMIZED CONTROLLER STUDY L'EFFETTO DEGLI ANESTETICI ALOGENATI SULLA SOPRAVVIVENZA AD UN ANNO DALL'INTERVENTO CARDIOCHIR... 2016-10-18 due-trials
Ongoing 2014-000385-22 Nerve Growth Factor eye drops as a novel treatment for vision loss in patients with Retinitis Pigmentosa: from preclinical to clinical Phase II trial. Nerve Growth Factor in collirio come trattamen... not-yet-due
Ongoing 2014-000986-30 Intravitreal Aflibercept for Choroidal Neovascularization Secondary to Angioid Streaks (EYLEA-STRIE) Aflibercept intravitreale per la neovascolarizzazione coroideale secondaria a Strie Angioidi (EY... not-yet-due
Reported results 2014-001456-39 Tranexamic acid in major vascular surgery (Tranex-AAA) Acido tranexamico nella chirurgia vascolare maggiore (Tranex-AAA) 2017-12-31 due-trials
Ongoing 2014-001532-11 MONO-INSTITUTIONAL PHASE II TRIAL ADDRESSING TOLERABILITY AND ACTIVITY OF R-CHOP CHEMOIMMUNOTHERAPY PRECEDED BY BLOOD-BRAIN BARRIER PERMEABILIZATION BY NGR-TUMOR NECROSIS FACTOR IN PATIENTS WITH RELAP... not-yet-due
Reported results 2014-003818-92 CUstodiol vs RInger: whaT Is the Best Agent? 2018-01-17 due-trials
Ongoing 2014-004110-28 A monocentric, open-label pilot study to assess the safety and efficacy of minimal islet transplantation in patients with new-onset type 1 diabetes. not-yet-due
Ongoing 2014-004244-35 AMYLOID LOAD IN PRODROMAL AD WITH LIMBIC-PREDOMINANT PHENOTYPE PRINCIPAL INVESTIGATOR - STUDIO DEL CARICO DI AMILOIDE IN AD PRODROMICO CON FENOTIPO LIMBICO not-yet-due
Exempt, with results 2014-004860-39 A phase I/II study evaluating safety and efficacy of autologous hematopoietic stem cells genetically modified with GLOBE lentiviral vector encoding for the human beta-globin gene for the treatment of ... 2019-11-25 not-yet-due
Completed, but no date, and reported results 2015-000679-28 Prognostic value of 18F-FAZA PET/CT in high grade glioma: comparison with MRI and correlation with hypoxia biomarkers. Ruolo prognostico della PET/TC con 18F-FAZA nei gliomi ad alto grado: confront... bad-data
Completed, but no date 2015-001206-33 A pilot phase II study of a nucleoside sparing regimen of Dolutegravir + Atazanavir/r in HIV-1 infected patients with detectable viremia (Dolatav Study) A pilot phase II study of a nucleoside spari... bad-data
Reported results 2015-001211-13 IMAGING OF NEUROINFLAMMATION AND NEURODEGENERATION IN ALZHEIMER’S DISEASE STUDIO DELLA NEUROINFIAMMAZIONE E NEURODEGENERAZIONE NELLA MALATTIA DI ALZHEIMER 2019-03-21 due-trials
Ongoing 2015-001888-39 PHARMACOGENOMICS HYPERTENSION : A NEW APPROACH FOR PERSONALIZED MEDICINE ( PGX - HT ) Farmaco-genomica dell'Ipertensione: un nuovo approccio per una medicina personalizzata (PGX-HT) not-yet-due
Ongoing 2015-002356-27 A multicentric, exploratory, non-randomised, non-controlled, prospective, open-label phase II, study evaluating safety and efficacy of IBU, G-CSF and Plerixafor as a stem cell mobilization regimen in ... not-yet-due
Ongoing 2015-004402-42 A pilot study assessing the effects of Ranolazine on coronary microvascular dysfunction in patients with hypertrophic cardiomyopathy A pilot study assessing the effects of Ranolazine on coronary mi... not-yet-due
Completed, but no date 2016-001774-15 THE ROLE OF 18F-FAZA PET IMAGING TECHNIQUE IN DETECTING LYMPH NODE METASTASES IN RENAL CELL CARCINOMA PATIENTS IL RUOLO DELLA TECNICA DI IMAGING TC/PET CON 18F-FAZA NELLA IDENTIFICAZIONE DELLE META... bad-data
Reported results 2016-002052-24 Continuous infusion versus intermittent administration of meropenem in critically ill patients. A multicenter randomized double blind trial. Continuous infusion versus intermittent administration o... 2022-11-03 due-trials
Completed, but no date, and reported results Terminated 2016-002413-22 Open label, Randomized (1:1), clinical trial to evaluate switching from dual regimens based on Dolutegravir plus a reverse transcriptase inhibitor to elvitegravir/cobicistat/emtricitabine/tenofovir a... bad-data
Ongoing 2016-003669-24 Amyloid PET imaging study for the diagnosis of Alzheimer's disease in the preclinical/predementia phase Studio della PET con tracciante per l’amiloide per la diagnosi della malattia di Alzheimer in... not-yet-due
Other 2016-004707-32 A Multi-Center, Open Label, Uncontrolled, Phase 2a Clinical Trial Evaluating the Safety and Efficacy of the Addition of Ibrutinib to Venetoclax through a MRD-guided Approach in Relapsed/Refractory Pat... not-yet-due
Completed, but no date Terminated 2016-004819-12 Discontinuation of first-line disease modifying treatment (DMT) in long-term full responders MS patients: a multicentre randomized clinical trial. Sospensione del trattamento di prima linea in pazi... bad-data
Reported results 2017-000554-19 Implication for strategies of long term control of viral replication in patient with primary HIV infection (PHI) treated with multitarget antiviral therapy (MT-ART) Strategie di controllo a lungo t... 2021-02-11 due-trials
Other 2017-001099-49 Clonal evolution in progressive CLL patients harboring subclonal TP53 aberrations treated with ibrutinib first-line Evoluzione clonale in pazienti con leucemia linfatica cronica in progressione por... not-yet-due
Exempt 2017-002430-23 A phase I/II study evaluating safety and efficacy of autologous hematopoietic stem and progenitor cells genetically modified with IDUA lentiviral vector encoding for the human α-L-iduronidase gene for... not-yet-due
Completed, but no date, and reported results Terminated 2017-004423-78 A phase II trial of allogeneic peripheral blood stem cell transplantation from family haploidentical donors in patients with myelodisplastic syndrome and acute leukemia under primary antifungal prophy... bad-data
Ongoing 2018-000487-28 Intravenous amino acid therapy for kidney protection in cardiac surgery: a multi-centre randomised blinded placebo controlled clinical trial Intravenous amino acid therapy for kidney protection in ... not-yet-due
Not reported 2018-000488-98 Proton pump inhibitors (PPI) as a new strategy for therapy in sepsis: clinical trial to reduce severity of organ failure and in vitro experiments to search specific hallmarks in monocytes from septic ... 2023-08-13 due-trials
Ongoing 2018-001034-18 Phase II monocentric study to evaluate a novel approach for staging prostate cancer patients by using a fully integrated hybrid PET/MRI Studio monocentrico di Fase II per valutare un approccio inno... not-yet-due
Ongoing 2018-001036-21 Phase II monocentric study on prostate cancer restaging using PET/MR with innovative radiotracers Studio monocentrico di fase II sulla ristadiazione del carcinoma prostatico mediante utilizzo della... not-yet-due
Exempt, with results Terminated 2018-001741-14 A phase I/II dose escalation study evaluating safety and activity of autologous CD34+-enriched hematopoietic progenitor cells genetically modified with a lentiviral vector encoding for the human inter... not-yet-due
Ongoing 2018-002548-10 PET/MRI study of amyloid burden in patients with Cerebral Amyloid Angiopathy-related inflammation Studio PET/MRI del carico di amiloide in pazienti con angiopatia amiloide cerebrale infiammatoria not-yet-due
Completed, but no date, and reported results 2019-001696-36 Study of efficacy of low-dose recombinant human interleukin-2 in immunological changes associated with depression (IL2REG) Studio di efficacia dell’interleuchina-2 ricombinante umana a basso dosagg... bad-data
Not reported 2019-002196-34 A Prospective Phase II Single-Arm Trial on Neoadjuvant Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE Followed by Surgery for resectable Pancreatic Neuroendocrine Tumors (Neo.Lu.Pa.NET) ... 2023-06-26 due-trials
Exempt 2019-003102-26 Therapeutic vaccination: A Phase I/II Randomized, Placebo-Controlled Trial of ChAdOx1.tHIVconsvX prime-MVA.tHIVconsvX Boost Vaccination Regimen in Early-treated durably-controlling HIV-1 positive Adul... not-yet-due
Other 2019-004782-40 An open label, single-arm, phase 2 study of neoadjuvant PEMbrolizumab before radical PROstatectomy (PEM-PRO) in high-risk prostate cancer patients Studio di fase 2, open-lable, a braccio singolo su... not-yet-due
Ongoing 2020-001014-37 Pharmacogenetics of hypertension: randomized monocentric study in patients with essential hypertension and treated with Spironolactone or Torasemide Farmacogenetica dell’ipertensione: studio monoce... not-yet-due
Completed, but no date, and reported results 2020-001513-20 Use of Defibrotide to reduce progression of acute respiratory failure rate in patients with COVID-19 pneumonia Uso di Defibrotide in infusione intravenosa per ridurre la progressione dell'insuffici... bad-data
Ongoing 2020-001795-15 A randomized, double blind, placebo-COntrolled trial of MavrilimumaB for Acute respiratory failure due To COVID-19 pneumonia with hyperinflammation: the COMBAT-19 trial Studio in doppio cieco rando... not-yet-due
Ongoing 2020-001987-28 PRECOV: a randomized controlled clinical trial on the effects of hydroxychloroquine in the prevention of COVID-19 in healthcare workers at risk PRECOV: studio clinico controllato e randomizzato sug... not-yet-due
Reported results Terminated 2020-002458-25 Randomized, controlled, open label, phase 2 clinical trial of Interferon-ß-1a (IFNß-1a) in COVID-19 patients. Studio randomizzato, controllato, in aperto, di fase 2 con Interferone-ß-1a (IFNß-1a) i... 2021-03-30 due-trials
Ongoing 2020-002949-42 A pilot study of chlorambucil in pre-treated metastatic pancreatic adenocarcinoma patients bearing a germ line BRCA or other DNA Defects Repair (DDR) mutations. Studio pilota sul clorambucile nel t... not-yet-due
Ongoing 2020-003183-68 The Role of Imaging Guided Surgery to Improve the Detection of LymphNode metastases in Prostate Cancer Patients Treated with Radical Prostatectomy and Extended Pelvic Lymph Node Dissection Il ruolo... not-yet-due
Completed, report not yet due 2020-004329-21 Reduction of progesterone elevation at trigger in poor responder Bologna’ criteria patients after controlled ovarian stimulation with long acting standard stimulation protocol compared with convention... 2024-05-06 not-yet-due
Other 2020-004409-30 Venetoclax and delayed rituximab with ibrutinib consolidation aiming at undetectable minimal residual disease (uMRD) in treatment-naïve patients with chronic lymphocytic leukemia (CLL) Venetoclax a... not-yet-due
Other 2020-004844-27 SURE-01_An open label, single-arm, phase 2 study of neoadjuvant sacituzumab govitecan, before radical cystectomy, for patients with muscle-invasive bladder cancer who cannot receive or refuse cisplati... not-yet-due
Other 2020-004876-16 SURE-02_An open label, single-arm, phase 2 study of perioperative pembrolizumab plus sacituzumab govitecan for patients with muscle-invasive bladder cancer who cannot receive or refuse cisplatin-based... not-yet-due
Ongoing 2020-005050-20 An open label, single-arm, phase 2 study od neoadjuvant nivolumab and nab-paclitaxel before cystectomy for patients with muscle-invasive bladder cancer Studio di Fase II, in aperto, a singolo bracc... not-yet-due
Ongoing 2020-005306-25 PIrfenidone to prevent fibrOsis in ARDS. A RaNdomizEd controllEd tRial (PIONEER) GR-2019-12371063 PIrfenidone to prevent fibrOsis in ARDS. A RaNdomizEd controllEd tRial (PIONEER) GR-2019-12371063 not-yet-due
Other 2020-005507-39 DECIPHERING IL-1 MEDIATED INFLAMMATION FOR THE TARGETED TREATMENT OF DILATED CARDIOMYOPATHY. Svelare l’infiammazione mediata da interleuchina-1 per il trattamento mirato della cardiomiopatia dilata... not-yet-due
Other 2020-006102-23 Study of a novel combination of immunovirologic and genetic parameters in early-treated HIV-1 patients undergone to antiretroviral therapy interruption (ATI) aimed at defining an algorithm predictive ... not-yet-due
Other 2021-000311-23 Fixed-duration therapy with ibrutinib and obinutuzumab (GA-101) in treatment-naïve patients with CLL Terapia a durata fissa con ibrutinib e obinutuzumab (GA-101) in pazienti con leucemia linfatica ... not-yet-due
Ongoing 2021-000722-96 Lymph Node Microenvironment Modifications in Patients with CLL Treated with Venetoclax-based regimens Modificazioni del microambiente linfonodali in pazienti con leucemia linfatica cronica CLL in t... not-yet-due
Other 2021-003577-63 Effects of ozanimod on myelin dynamics and neurodegeneration in patients with relapsing-remitting multiple sclerosis: correlation with disease activity, cognition, fatigue, depression and quality of l... not-yet-due
Other 2021-004189-37 Role of Hydroxychloroquine in therapeutic strategy of Head and Neck cancer and Non-small cell lung cancer Il ruolo dell'idrossiclorochina nella strategia dei tumori del distretto Testa e Collo e ne... not-yet-due
Ongoing 2022-003703-16 The effect of phoSPHocreatine on mEdical emergency team (met) tREated patients: a randomized clinical trial protocol - SPHERE. L'effetto della phoSPHocreatina sui pazienti trattati dal team di emer... not-yet-due
Ongoing 2022-003787-24 Precision Medicine in patients with unresectable CholAngiocarcinoma; RadioEmbolization and combined biological therapy (Single arm, multicenter phase II study investigating the efficacy and safety of... not-yet-due
Other 2022-003853-70 Towards a personalized precision medicine in rare disease: tirzepatide (a dual glucose­ dependent insulinotropic polypeptide and glucagon-like peptide-I receptor agonist) monotherapy in patients with ... not-yet-due
Other 2022-003905-31 Fully hybrid 18F-PSMA PET/MRI as one-stop approach for the diagnosis of clinically significant prostate cancer Ruolo della metodica PET/MRI con 18F-PSMA come approccio di imaging integrato nella di... not-yet-due
Other 2022-003916-10 Deciphering B and T cell Co-stimulation for the Targeted Treatment of IgG4-Related Disease Analisi della co-stimolazione B-T cellulare per la terapia personalizzata della Malattia IgG4-correlata not-yet-due